Reviva Pharmaceuticals Files 8-K
Ticker: RVPH · Form: 8-K · Filed: Apr 15, 2026
Sentiment: neutral
Topics: 8-k, disclosure
Related Tickers: RVPH
TL;DR
RVPH filed an 8-K on 4/15/26, check for updates.
AI Summary
Reviva Pharmaceuticals Holdings, Inc. filed an 8-K on April 15, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). The filing includes an XBRL 8-K document and Exhibit 99.1, with financial statements and exhibits also noted. The company's mailing and business address is 10080 N Wolfe Road, Suite SW3-200, Cupertino, CA 95014.
Why It Matters
This 8-K filing indicates that Reviva Pharmaceuticals Holdings, Inc. is making disclosures relevant to investors and the public, potentially impacting its stock valuation.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no immediate indication of significant negative events.
Key Players & Entities
- REVIVA PHARMACEUTICALS HOLDINGS, INC. (company) — Filer
- 0001742927 (company) — CIK Number
- 2026-04-15 (date) — Filing Date
- 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 (location) — Mailing and Business Address
FAQ
What specific information was disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure, only that it was made under Item 7.01.
What are the 'Other Events' reported in Item 8.01?
The filing does not detail the specific 'Other Events' covered under Item 8.01.
When was the 8-K filing accepted by the SEC?
The 8-K filing was accepted on 2026-04-15 at 08:05:13.
What is the CIK number for Reviva Pharmaceuticals Holdings, Inc.?
The CIK number for Reviva Pharmaceuticals Holdings, Inc. is 0001742927.
What is the SIC code for Reviva Pharmaceuticals Holdings, Inc.?
The SIC code for Reviva Pharmaceuticals Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2026 regarding REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH).